Hypoparathyroidism is a condition where an individual's body does not secrete enough parathyroid hormone (PTH). Without enough PTH, the body is unable to properly regulate phosphorus and calcium ...
CHRONIC idiopathic hypoparathyroidism is a rare disease that may be identified if the clinical features of chronic tetany are recognized and confirmed by appropriate chemical and ...
World Hypopara Awareness Day was established to shine a light on hypoparathyroidism and the challenges faced by those living ...
Expert Rev Endocrinol Metab. 2012;7(3):255-257. The future of hormone replacement therapy in hypoparathyroidism can be viewed with optimism, even if we are left with several unanswered questions ...
The information provided in response to the FDA’s Complete Response Letter "constituted a major amendment to the NDA" requiring more time for review. The Food and Drug Administration (FDA) has ...
In a phase 2 trial, 93% of eneboparatide-treated patients were able to discontinue standard of care therapy. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Entera Bio (ENTX – Research Report). The associated price ...
More severe symptoms include seizures and heart failure. Surgical hypoparathyroidism describes an underactive parathyroid gland and is the most common cause of low calcium levels. Surgical ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a meme frenzy, any positive news related to a company has a ...
Opens in a new tab or window The FDA granted a fast track designation to eneboparatide for hypoparathyroidism, said developer Amolyt Pharma. Surgical premature menopause was linked with higher ...
Estelle Marsha Berliant, nee Abrams, age 84, beloved wife of Marvin White, Jr.; loving mother of Allan (Kim) Berliant and Alyse (Steve Volberding) Poteshman; adored Grammy of Danielle Poteshman, ...
Oral, small molecule parathyroid hormone 1 receptor (PTH1R) agonist maintained serum calcium control over 28-day dosing in a preclinical hypoparathyroidism model PTH1R program for hypoparathyroidism ...